Northwest Biotherapeutics reported $-3.4M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Agenus USD 39.17M 49.8M Mar/2026
AstraZeneca USD 2.51B 573M Jun/2026
Bristol-Myers Squibb USD 3.32B 640M Jun/2026
Celldex Therapeutics USD -73.5M 5.18M Jun/2026
Eisai JPY 18.24B 21.49B Jun/2026
Merck USD -1.34B 2.9B Jun/2026
Northwest Biotherapeutics USD -3.4M 23.78M Mar/2026
Pfizer USD -248M 2.94B Jun/2026
Plus Therapeutics USD -6.95M 1.23M Mar/2026
Roche Holding CHF 6.87B 1.4B Jun/2026